Listeria

Listeria names a group of bacteria. Listeria monocytogenes is the main cause of human listeriosis, but a stool result labeled only Listeria does not establish that this species was detected. Even confirmed detection of L. monocytogenes in stool can occur without illness.

What This Test Picks Up

This assay uses quantitative PCR, abbreviated qPCR, to detect and estimate bacterial DNA in stool. The method copies selected DNA sequences and measures the signal produced during that process. The available test details do not specify its gene target or which Listeria species it detects, so species-specific interpretation requires confirmation of the laboratory's assay coverage.

Your result is reported in CFU/g stool. CFU stands for colony-forming units. In a culture, these units describe bacteria that grow into colonies under the laboratory's conditions. With qPCR, the reported amount is inferred from DNA using the laboratory's calibration. It is not a direct count of living bacteria, and the unit alone does not make it interchangeable with a culture result.

For preventive screening and numerical tracking, this is an exploratory measurement. Published carriage studies have not established a stool qPCR level that predicts invasive infection, pregnancy complications, or a benefit from treatment aimed at lowering the number. The established clinical importance of L. monocytogenes does not establish the usefulness of screening healthy people with this assay.

What Human Carriage Studies Found

The most relevant studies measured L. monocytogenes specifically in human stool. They provide context for carriage, but they did not validate this catalog assay or the interpretation of its CFU/g stool results.

In a year-long survey of three healthy adults who each collected stool samples repeatedly, PCR detected L. monocytogenes in a small share of samples, and culture found it less often. Positive runs were short, lasting a few consecutive days, and none coincided with overt illness. This small study shows that symptom-free, intermittent detection happens. It cannot establish a maximum duration of carriage for everyone.

A French study tested stool from 900 people without diarrhea and 125 people with diarrhea. Species-specific PCR detected L. monocytogenes DNA in 10% of the first group and 20.8% of the second. Detection was about twice as common with diarrhea, but the comparison did not establish that the organism caused each person's symptoms. The researchers also could not distinguish living organisms from dead organisms using that assay.

Culture-based studies of healthy adults have generally found lower carriage rates, roughly 1 to 5%. The gap reflects PCR's greater sensitivity and its ability to pick up DNA from bacteria that are no longer alive.

Human datasets linked carriage with differences in the other bacteria living in the gut. Experiments supporting a causal role for the gut bacterial community were performed in mice. These findings do not establish a way to interpret an individual microbiome profile as protection against listeriosis.

Why Pregnancy and Immune Health Matter

Invasive listeriosis occurs when the infection spreads beyond the intestine. During pregnancy, an infected person may feel well or have a mild flu-like illness while the infection threatens the pregnancy or newborn. Documented complications include pregnancy loss, early delivery, and severe newborn infection.

Outside pregnancy, serious illness occurs especially in adults aged 65 and older and people with weakened immune defenses. Cancer, diabetes, kidney or liver disease, and treatments such as chemotherapy or immune-suppressing steroids can increase susceptibility. Infection can involve the bloodstream or the brain and its surrounding tissues.

The French MONALISA study followed 818 people with microbiologically confirmed listeriosis and documented severe outcomes in bloodstream, neurological, and pregnancy-associated disease. These were established infections. Their outcomes cannot be used to calculate your risk from an isolated stool DNA finding.

Diagnosis of invasive disease generally relies on blood cultures and, depending on the symptoms, spinal fluid or pregnancy-related specimens. These samples answer different questions from stool. Neither a positive nor a negative stool result establishes whether infection has reached those sites.

Diarrhea and Inflammatory Bowel Disease

L. monocytogenes can cause an intestinal illness with diarrhea and vomiting, sometimes with fever. Many cases are brief and mild. A positive stool DNA result still needs to be interpreted with symptoms and other possible causes, including other infections.

An older study examined intestinal biopsies, a different specimen from stool, using a different PCR method. L. monocytogenes DNA appeared in about 5 to 6% of biopsies from people with inflammatory bowel disease and about 18% of control biopsies. The organism was not enriched in the inflammatory bowel disease samples. This study did not establish it as a cause of Crohn's disease or ulcerative colitis, or validate stool qPCR for identifying the cause of either condition.

When Results Can Be Misleading

• Species coverage: a result reported as Listeria may cover more than L. monocytogenes. Clinical findings about that species cannot automatically be assigned to every member of the group.
• Intermittent detection: the amount detected can change between samples. A negative sample cannot establish that an earlier exposure never happened.
• DNA from dead bacteria: standard qPCR can detect DNA after bacteria have died. A positive result does not by itself demonstrate living organisms or active infection.
• Stool interference: substances in stool can hinder PCR, and DNA extraction efficiency can affect detection and the estimated amount. Laboratory controls help identify these problems.
• Small amounts of DNA: results near an assay's detection limit can be less reproducible, and an amount may be detectable without being reliably quantifiable.
• Method and laboratory differences: species coverage, DNA targets, extraction procedures, and calibration can differ. Numbers from different assays, or from qPCR and culture, should not be treated as interchangeable.